| Application no. and date | 19717173.9 (espacenet) (Federated) (European Patent Register), 20190329 | | Patent/reg. no. and date | DK/EP 3773910, 20240724 | | Publication date | 20210217 | | Priority no. and date | US 201862650277 P, 20180329 | | EP pub. no. and date |
EP 3773910 20210217 | | Effective date | | | Applicant/owner | Ambrx, Inc., 10975 North Torrey Pines Road
La Jolla, CA 92037, US | | Applicant ref. no. | V478581DK00 | | Inventor | Brady, William, 618 219th Place SW
Bothell, WA 98021, US,
TIAN, Feng, 8374 Orange Haven Place
San Diego, CA 92129, US,
BHOWMIK, Shivarupam, 11824 Bernardo Terrace, Unit E
San Diego, CA 92128, US,
WANG, Jianing, 8 Spruce Ave, 8
Cambridge, MA 02138, US,
XIA, Jinming, 593 Edgewater Ave
Oceanside, CA 92057, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07K 16/30 (2006.01) | | Title | Humaniseret anti-prostata-specifikt membranantigen(PSMA)-antistof-lægemiddelkonjugater | | Int. application no. | US2019025057 | | Int. publication no. | WO2019191728 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
